The prostaglandins (PGs) are a group of naturally occurring acidic lipids, ubiquitous in mammalian tissues and possess diverse biological activity. The cardiovascular actions of these compounds have been extensively investigated and in most peripheral vascular beds E-type prostaglandins are potent vasodilators, whereas PGF
2α is a weak vasoconstrictor agent.
The present investigation was conducted to compare the effects of prostaglandins E
1, E
2, D
2, F
2α and I
2 on the canine airways and pulmonary vascular bed.
Thirty-two mongrel dogs, weighing between 18 and 28kg, were anesthetized with intravenous administration of 25mg/kg of sodium pentobarbital. The left hemithorax was opened under artificial respiration. Catheters were inserted into the pulmonary artery trunk, left atrium and left femoral artery, and pulmonary artery pressure (Ppa), left atrium pressure (Pla) and femoral artery pressure (Pfa) were measured using pressure transducers. The noncannulating electromagnetic flow probes were placed around the ascending aorta and the pulmonary artery of left lower lobe, and cardiac output (Qaorta) and blood flow of the left lower lobe (Q
lll) were measured, respectively. Drugs were injected into the left pulmonary artery and the left femoral vein through polyethelene catheter.
1) Ptr, Pla and Pfa decreased and Qaorta increased dose-dependently by an injection of PGE
1 and PGE
2 into left pulmonary artery, while PGE
1 caused a decrease and PGE
2 an increase in Ppa, and PGE
1 caused an increase and PGE
2 a decrease in Q
lll.
2) Ptr, Ppa and Pfa increased, Pla and Qaorta decreased dose-dependently by an injection of PGF
2α into the left pulmonary artery.
3) Ptr and Ppa increased, and Q
lll decreased dose-dependently by an injection of PGD
2 into the left pulmonary artery.
4) Ppa, Pla and Pfa decreased, Qaorta and Q
lll increased dose-dependently by an injection of PGI
2 into left pulmonary artery.
5) The above results suggest that these PGs may act on the pulmonary vascular, tracheobronchial and pulmonary lymphatic systems, ameliorating the ventilation perfusion ratio and modulating pulmonary circulation.
抄録全体を表示